JAAD Paper Reconsiders Occipital Scalp in Advanced Hair Loss

By Daniel Okafor

A November 2026 paper in the Journal of the American Academy of Dermatology questions a clinical reflex that has guided hair-loss surgery for decades. Five authors argue the occipital scalp may not stand as a reliable control in advanced androgenetic alopecia.

Derek Maas, Archie Spindler, Isabella Zappi, Jerry Shapiro, and Kristen I. Lo Sicco co-wrote "Rethinking the occipital scalp as a control in advanced androgenetic alopecia." The piece landed in JAAD Volume 95, Issue 5. Shapiro and Lo Sicco carry weight in hair-restoration dermatology. Their names on the paper signal the stakes.

What role has the occipital scalp played?

The patch at the back of the head has long served as a stable reference zone. Surgeons measure density, hair-shaft caliber, and miniaturization there before comparing findings against a thinning vertex. Follicular-unit transplantation pulls donor grafts from the same region. The reason is simple: androgen-driven loss rarely strikes it.

That assumption underwrites every standard alopecia consult in clinics from coast to coast.

Why revisit it now?

The paper targets a specific patient cohort: those with advanced androgenetic alopecia. Late-stage disease pushes beyond Norwood stage III vertex patterns. Hair loss reaches stages V, VI, and VII. Density drops across the entire crown. Diffuse thinning sometimes bleeds into the mid-scalp and occipital zones.

The authors' central challenge is direct. If the reference scalp itself shows disease activity, the comparison collapses. Surgical planning loses its anchor. Medical assessments lose their yardstick.

What's missing from the early reports?

Readers looking for effect sizes, biopsy findings, sample counts, or statistical comparisons will need the full JAAD text. What the title promises is conceptual reframing. That framing alone will spark discussion at dermatology meetings next spring.

What shifts in clinical practice?

Three practice moves follow if the framing holds. Pre-operative densitometry should expand into lower occipital zones. Graft-harvesting maps may need recalibration for advanced-stage patients. Candid conversations with patients about realistic outcomes become more important, because donor supply may not be as generous as older models suggested.

None of these moves cost much clinic time. All three tighten the assessment.

Who stands behind the paper?

Shapiro's decades of work on scarring alopecias and Lo Sicco's transplant research anchor the author list. Maas, Spindler, and Zappi round out the team. Their combined credibility lifts the publication's reach across the field.

Publication in JAAD — dermatology's flagship — suggests editorial vetting matched the gravity of the claim.

What's the broader signal?

Expect commentaries, letters, and follow-up studies within twelve months. The title alone reframes a clinical default that has held since the 1980s.

What should readers take away?

Dermatologists may need to retire the "occipital scalp is always normal" shortcut. Advanced alopecia changes the rules. Watch the next issue of JAAD for the paper's methods and data.

Derm Field will track follow-up research as it appears.

Daniel Okafor covers dermatology and aesthetic medicine for Derm Field.